华恒生物：拟发行H股股票并在香港联交所主板挂牌上市

Group 1 - The company plans to issue overseas listed foreign shares (H-shares) and apply for listing on the Hong Kong Stock Exchange main board [1] - The initiative aims to advance the company's globalization strategy, enhance brand influence and core competitiveness, and consolidate its leading position in the industry [1] - The company seeks to leverage the resources and mechanisms of international capital markets to optimize its capital structure and diversify financing channels [1] Group 2 - The proposal will be submitted for approval at the company's shareholders' meeting [1]